Unprecedented level of scientific discourse at INNOVATE
Hussein Tawbi, Professor at The University of Texas MD Anderson Cancer Center, shared a post by Liz Burton, Executive Director of Strategic Translational Research Initiative Development at The University of Texas MD Anderson Cancer Center, on X, adding:
“An absolutely amazing meeting, expertly organized by Liz Burton, Christian Blank and the best host ever Paolo A. Ascierto. Unprecedented level of scientific discourse, realistic assessment of current state, and ambitious vision of a future where patients derive maximum benefit from neoadjuvant immunotherapy approaches across all cancers. Congratulations and looking forward to future editions.”
Quoting Liz Burton‘s post:
” What a humbling opportunity to organize and co-chair the first International Neoadjuvant Immunotherapy Across Cancers (INNOVATE) mtg in Naples with Paolo A. Ascierto and Christian Blank bringing together critical leaders for 2 days of deep discussion.
Representation from multiple disciplines in academia, ESMO and SITC presidents (Giuseppe Curigliano, Emens Leisha), and pharma. Much progress made, and much more to come. Many thanks to our speakers and session chairs, for their expertise, participation, and leadership!”
Source: Hussein Tawbi/X and Liz Burton/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023